End Stage Renal Disease
Conditions
Interventions
L group:local infiltration anesthesia
Uni-TAP group:unilateral TAP block with 0.25% ropivacaine 40ml
Bi-TAP group:bilateral TAP block with 0.25% ropivacaine 20ml
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with end stage renal diseases who are willing to take TAP block as one option of anesthesia techniques.
Exclusion criteria
Exclusion criteria: Patients with known allergic history to local anesthetics; Patients with severe coagulopathy (PT or/and APTT >200% normal upper range)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| plasma ropivacaine concentration;visual analogue scale of pain;satisfaction rate with anesthesia in patients;satisfaction rate with anesthesia in surgeons;hemodynamics in different time points;rate of switching to general anesthesia; | — |
Secondary
| Measure | Time frame |
|---|---|
| rescue sufentanil dosage; | — |
Countries
China
Contacts
Public ContactQi Li
West China Hospital, Sichuan University
Outcome results
None listed